Health economic evaluation of gene replacement therapies: methodological issues and recommendations.
Aballéa S, Thokagevistk K, Velikanova R, Simoens S, Annemans L, Antonanzas F, Auquier P, François C, Fricke FU, Malone D, Millier A, Persson U, Petrou S, Dabbous O, Postma M, Toumi M.
Aballéa S, et al. Among authors: toumi m.
J Mark Access Health Policy. 2020 Oct 11;8(1):1822666. doi: 10.1080/20016689.2020.1822666.
J Mark Access Health Policy. 2020.
PMID: 33144927
Free PMC article.